bupropion and tyramine

bupropion has been researched along with tyramine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fowle, AS; Peck, AW; Rogers, HJ; Spector, RG	2
Andrade, CH; Barbosa-Filho, JM; Capibaribe, VC; Carvalho, AMR; Chaves Filho, AJM; Chaves, RC; Fonteles, MMF; Gutierrez, SJC; Macedo, DS; Mallman, ASV; Mottin, M; Oliveira, ICM; Oliveira, NF; Rebouças, MO; Sartori, DP; Silva, DMA; Sousa, FCF; Valentim, JT	1

Reviews

1 review(s) available for bupropion and tyramine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for bupropion and tyramine

Article	Year
Failure of bupropion to affect tyramine response in man. The Journal of clinical psychiatry, 1983, Volume: 44, Issue:5 Pt 2 Topics: Adult; Antidepressive Agents; Blood Pressure; Bupropion; Dose-Response Relationship, Drug; Humans; Imipramine; Male; Propiophenones; Tyramine	1983
Failure of bupropion to affect the response to tyramine in man. British journal of clinical pharmacology, 1981, Volume: 12, Issue:1 Topics: Adult; Blood Pressure; Bupropion; Humans; Imipramine; Male; Propiophenones; Tyramine	1981

Other Studies

1 other study(ies) available for bupropion and tyramine

Article	Year
Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches. Behavioural brain research, 2020, 04-06, Volume: 383 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Imipramine; Mice; Molecular Docking Simulation; Monoamine Oxidase; Norepinephrine; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tyramine	2020

Article

Year

Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.

Behavioural brain research, 2020, 04-06, Volume: 383

Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Imipramine; Mice; Molecular Docking Simulation; Monoamine Oxidase; Norepinephrine; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tyramine

2020